Wellington Management Group LLP Entrada Therapeutics, Inc. Transaction History
Wellington Management Group LLP
- $548 Billion
- Q2 2024
A detailed history of Wellington Management Group LLP transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 1,033,927 shares of TRDA stock, worth $17.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,033,927
Previous 1,026,840
0.69%
Holding current value
$17.8 Million
Previous $14.6 Million
1.26%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding TRDA
# of Institutions
87Shares Held
27.8MCall Options Held
100Put Options Held
0-
Baker Bros. Advisors LP New York, NY4.87MShares$83.8 Million0.92% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$76.3 Million34.63% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$76 Million29.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.13MShares$54 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$29.2 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $540M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...